SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.23 CNY | +1.36% |
|
+3.72% | -28.98% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shenzhen Neptunus Bioengineering Co.,Ltd is a China-based company principally engaged in pharmaceutical and food manufacturing and pharmaceutical commercial distribution businesses. The Companyâs main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. The Company distributes its products mainly in domestic market, with East China as its main market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -28.98% | 847M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B |
- Stock Market
- Equities
- 000078 Stock
- News Shenzhen Neptunus Bioengineering Co., Ltd.
- Shenzhen Neptunus Bioengineering to Set Up 150 Million Yuan Medical Equipment Unit
